The "Global Spatial OMICS Market, By Sample Type, By End Use, By Technology, By Product, By Workflow, Estimation & Forecast, 2018 - 2028" report has been added to ResearchAndMarkets.com's offering.
The global spatial OMICS market held a market value of USD 230.2 million in 2020 and is estimated to reach USD 506.6 million by the year 2028. The market is anticipated to register a CAGR of 10.3% during the forecast period.
- 10x Genomics
- S2 Genomics, Inc.
- NanoString Technologies
- Seven Bridges Genomics
- PerkinElmer, Inc.
- Danaher Corporation
- IonPath, Inc.
- Millennium Science Pty Ltd
- Akoya Biosciences, Inc.
- Fluidigm Corporation
- Diagenode Diagnostics
- Biognosys AG
- Rebus Biosystems
- Ultivue, Inc.
- BioSpyder Technologies
Spatial omics combines the molecular scrutiny with spatial data on the cell's localization in the interior of the tissue. Omics is a term brief for numerous diverse studies, such as epigenomics, genomics, transcriptomics, lipidomics proteomics, and metabolomics, among others.
The spatial OMICS market drivers include high applications as diagnostics tools, especially in oncology area. The growing cancer prevalence and incidence rates drive the market growth. Moreover, the high research and development carried out by private and public agencies boost the market growth. For instance, Ting Wu, a professor of genetics in the Blavatnik Institute at Harvard Medical School (HMS), created innovations that multiplex Oligopaint pipeline protocols and reagent methods, coupled with analysis techniques to generate a shorter time-to-result and more cost-effective approach to unswervingly envision the genome, spatially and in situ. Many aspects of this capability were highlighted in a 2020 publication in Nature Methods, thus generating a high level of awareness.
On the other hand, the lack of skilled technical professionals in developing, underdeveloped, and even few developing countries, curb the growth rate of this industry.
Growing potential of spatial OMICS as a cancer diagnostic tool
Many emerging spatial OMICS technologies and advancements aid in the growth of the spatial OMICS market. For instance, spatial transcriptomics (ST) is an in situ capturing method, allowing quantification and visualization of transcriptomes in individual tissue sections. The application of spatial OMICS techniques in cancer diagnosis promises huge results for the near future.
Increasing adoption of spatial OMICS in drug discovery and development
Companies are utilizing spatial OMICS in understanding molecules during clinical trial studies. Drug discovery is a crucial phase in the overall clinical studies, and the utilization of spatial OMICS in drug development and discovery phases aids substantial growth currently and in the near future for the spatial OMICS market over the forecast period. For instance, Cancer Transcriptome Atlas by Nanostring is the first commercial GeoMx product that is enabled by readout using NGS. It includes over 1,800 genes and 100 pathways and provides a 20-fold increase in RNA coverage resulting in a high-resolution spatial view of cancer biology.
The global spatial OMICS market is segmented into sample type, end-use, technology, product, and workflow.
By Sample Type
- Fresh Frozen
The FFPE segment is held the largest market share of around 55% owing to the rise in examination, experimental research, and diagnostic progress. Moreover, the fresh frozen segment is projected to be the fastest growing owing to the steady demand rise.
By End Use
- Academic & Translational Research Institutes
- Pharmaceutical and Biotechnology Companies
The academic & translational research institutes segment held the largest share owing to a surge in government grants, funds for research, as well as the increased research focus on spatial genomics and other areas.
- Spatial Proteomics
- Spatial Transcriptomics
- Spatial Genomics
The spatial genomics segment is anticipated to grow the fastest with a CAGR of 12.3% due to the rise in chronic diseases. The launch of novel tools and instruments in this area drives the growth of this segment.
The consumables segment is anticipated to hold a substantial share and cross USD 200 million market value by 2026. Mounting use of consumables, coupled with increasing applications of spatial transcriptomics in numerous fields, including drug discovery, drug development and biomarker identification drives the growth of this segment.
- Sample Preparation
- Instrumental Analysis
- Data Analysis
The sample preparation segment is estimated to be the fastest growing segment owing to the rise in research studies, and clinical trial drug candidates. The market value of the segment is projected to hit USD 154 million in 2028.
By region, the global spatial OMICS market is divided into Europe, North America, Asia Pacific, Middle East & Africa, and South America.
For more information about this report visit https://www.researchandmarkets.com/r/470xjh
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.